What are the guarantees for the implementation of the recommended doses of vaccination against malaria?! – #The_Autre_Dimension – ✍️ Musaab Brier
» In October 2023, the World Health Organization recommended the use of a new vaccine, known as R21/Matrix-M, to prevent malaria in children. This recommendation follows advice provided by WHO through the Strategic Advisory Group of Experts on Immunization and the Malaria Policy Advisory Group, and was endorsed by the Director-General of WHO following the regular biannual meeting of the Expert Advisory Group on Immunization, held September 25-29.
» The R21 vaccine is the second malaria vaccine recommended by the organization, following the RTS vaccine, S/AS01, which received a recommendation from the organization in 2021. Both vaccines have been shown to be safe and effective in preventing malaria in the children. , and are expected to have a significant impact on public health when introduced on a large scale.
» Malaria, a mosquito-borne disease, places a particularly heavy burden on children in Africa, where nearly half a million children die from it each year.
» Dr Tedros Adhanom Ghebreyesus, Director-General of the Organization, said: “As a malaria researcher, I have often dreamed of the day when we find a safe and effective vaccine against malaria. We now have two vaccines, not just one. ” He added: “Demand for the RTS,S vaccine far exceeds supply, so the R21 vaccine is a very important additional tool, providing protection to more children at a faster rate and bringing us closer to our vision of a world without malaria. world.”
» Key features of the R21 malaria vaccine: WHO's updated recommendations for the malaria vaccine are based on evidence from ongoing clinical trials of the R21 vaccine and other studies, which have shown high effectiveness when used administered just before peak transmission season: in areas with high seasonal transmission rates. malaria transmission (During which malaria transmission is largely limited to 4 or 5 months per year).
» The R21 vaccine has been shown to reduce cases of symptomatic malaria by 75% over the 12 months following administration of a three-dose series of the vaccine. The fourth dose, administered one year after the third dose, maintained the same effectiveness. This vaccine has similar efficacy to the RTS,S vaccine when administered on a seasonal basis.
After the last one:
In summary, we congratulate Sudan for the introduction of this important malaria vaccine, and we encourage citizens to be careful to vaccinate their children with it, but I emphasize the need to implement the protocols recommended in the implementation implementation of targeted doses based on the approved timing. Finally, what has been done about the gap in the availability of malaria vaccine doses? We have not received any response from Federal Health regarding the need to take the second dose within a specific time frame to ensure the effectiveness of the vaccine. vaccination for the announced periods, and the question is it prohibited?!
There is no revealer besides God
God is sufficient for us and He is the best arranger of affairs
O God, do not impose on us, because of our sins, those who do not fear you for us and do not have pity on us, O Most Merciful of the merciful.
#TheOther_Dimension | Brier Musaab
